Showing results (371-380 of 443) with videos related to

Sort By:
Pageof 45
Scientific Reports|September 15, 2020
Short-term behavioural impact contrasts with long-term fitness consequences of biologging in a long-lived seabirdNatasha Gillies, Annette L Fayet, Oliver Padget, et al.
Antiviral Therapy|March 31, 2011
Successful efavirenz dose reduction guided by therapeutic drug monitoringAurélie Fayet Mello, Thierry Buclin, Laurent A Decosterd, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 1, 2009
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirineA Fayet, A Béguin, B Zanolari, et al.
Therapeutic Drug Monitoring|July 22, 2008
Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fractionAurélie Fayet, Alexandre Béguin, Begona Martinez de Tejada, et al.
Trials|May 14, 2025
Clinical trial budgeting approaches in Switzerland-a meta-research studyAlexandra Griessbach, Malena Chiaborelli, Klaus Ehrlich, et al.
Ecology and Evolution|December 16, 2022
A new biologging approach reveals unique flightless molt strategies of Atlantic puffinsJamie Hendrick Darby, Mike P Harris, Sarah Wanless, et al.
Bulletin Du Cancer|September 6, 2025
[Evaluation of a consultation dedicated to informal caregivers in a cancer treatment centre]Noémie Escot, Anne-Sophie Baudry, Clémence Bouffay, et al.
Clinical Pharmacology and Therapeutics|February 20, 2009
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individualsM Arab-Alameddine, J Di Iulio, T Buclin, et al.
Annals of Neurology|December 26, 2022
Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis ThymusCloé A Payet, Axel You, Odessa-Maud Fayet, et al.
Pageof 45